טוען...
Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry
BACKGROUND: In patients with type-2 diabetes receiving oral antidiabetic drugs (OADs), the addition of insulin is frequently required to achieve sufficient control over blood glucose levels. It is, however, difficult to predict if, when and in which patients insulin therapy will be needed. We aimed...
שמור ב:
| הוצא לאור ב: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4597397/ https://ncbi.nlm.nih.gov/pubmed/26446863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-015-0051-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|